E-LIB Suche - Ergebnisse für: Gonzalez-Fierro, Aurora

1

Selection of clinically relevant drug concentrations for in..:

Robles-Bañuelos, Benjamin ; Romo-Perez, Adriana ; Dominguez-Gomez, Guadalupe...
Clinical and Translational Oncology. 26 (2023) 5 - p. 1077-1088 , 2023

Link: https://doi.org/10.1007/..

2

Does Therapeutic Repurposing in Cancer Meet the Expectation..:

Gonzalez-Fierro, Aurora ; Romo-Pérez, Adriana ; Chávez-Blanco, Alma..
Clinical Drug Investigation. 43 (2023) 4 - p. 227-239 , 2023

Link: https://doi.org/10.1007/..

3

Drug repurposing for cancer therapy, easier said than done:

Gonzalez-Fierro, Aurora ; Dueñas-González, Alfonso
Seminars in Cancer Biology. 68 (2021) - p. 123-131 , 2021

Link: https://doi.org/10.1016/..

4

Barriers for Pharmaceutical Innovation With Focus in Cancer..:

Duenas-Gonzalez, Alfonso ; Gonzalez-Fierro, Aurora
Therapeutic Innovation & Regulatory Science. 54 (2020) 2 - p. 342-352 , 2020

Link: https://doi.org/10.1007/..

5

Barriers for Pharmaceutical Innovation With Focus in Cancer..:

Duenas-Gonzalez, Alfonso ; Gonzalez-Fierro, Aurora
Therapeutic Innovation & Regulatory Science. , 2019

Link: https://doi.org/10.1177/..

6

Epigenetic Therapy With Hydralazine and Magnesium Valproate..:

Cervera, Eduardo ; Candelaria, Myrna ; López-Navarro, Omar...
Clinical Lymphoma Myeloma and Leukemia. 12 (2012) 3 - p. 207-212 , 2012

Link: https://doi.org/10.1016/..

7

DNA Methylation-Independent Reversion of Gemcitabine Resist..:

Candelaria, Myrna ; de la Cruz-Hernandez, Erick ; Taja-Chayeb, Lucia...
PLoS ONE. 7 (2012) 3 - p. e29181 , 2012

Link: https://doi.org/10.1371/..

8

Acetylator status and N-acetyltransferase 2 gene polymorphi..:

Taja-Chayeb, Lucia ; González-Fierro, Aurora ; Miguez-Muñoz, Cristian...
Pharmacogenetics and Genomics. 21 (2011) 12 - p. 894-901 , 2011

Link: https://doi.org/10.1097/..

9

A double-blind, placebo-controlled, randomized phase III tr..:

Coronel, Jaime ; Cetina, Lucely ; Pacheco, Irlanda...
Medical Oncology. 28 (2010) S1 - p. 540-546 , 2010

Link: https://doi.org/10.1007/..

10

Hydralazine and magnesium valproate as epigenetic treatment..:

Candelaria, Myrna ; Herrera, Aquileo ; Labardini, Juan...
Annals of Hematology. 90 (2010) 4 - p. 379-387 , 2010

Link: https://doi.org/10.1007/..

11

Weekly topotecan as second- or third-line treatment in pati..:

Coronel, Jaime ; Cetina, Lucely ; Candelaria, Myrna...
Medical Oncology. 26 (2008) 2 - p. 210-214 , 2008

Link: https://doi.org/10.1007/..

12

The prince and the pauper. A tale of anticancer targeted ag..:

Dueñas-González, Alfonso ; García-López, Patricia ; Herrera, Luis...
Molecular Cancer. 7 (2008) 1 - p. 82 , 2008

Link: https://doi.org/10.1186/..

13

A proof-of-principle study of epigenetic therapy with hydra..:

Arce, Claudia ; Perez-Plasencia, Carlos ; Gonzalez-Fierro, Aurora...
BMC Cancer. 7 (2007) S1 - p. , 2007

Link: https://doi.org/10.1186/..

14

Epigenetic therapy with hydralazine and valproate associate..:

Candelaria, Myrna ; Cetina, Lucely ; Garcia, Alicia...
BMC Cancer. 7 (2007) S1 - p. , 2007

Link: https://doi.org/10.1186/..

15

A phase II study of epigenetic therapy with hydralazine and..:

Candelaria, Myrna ; Gallardo-Rincón, Dolores ; Arce, Claudia...
BMC Cancer. 7 (2007) S1 - p. , 2007

Link: https://doi.org/10.1186/..